Learning Courage celebrates 4 years helping schools eradicate sexual misconduct and abuse

CEO Jamie Forbes shares his recovery from sexual abuse in his just released TEDx Talk PORTSMOUTH, N.H., June 6, 2023 /PRNewswire/ — Learning Courage, a leading nonprofit founded by sexual abuse survivors, was created to work with school leaders to reduce and respond to sexual misconduct in schools. By providing practices, insights and resources, Learning … Read more

Executive Home Care Offers Profitable Franchise Ventures in the Thriving Home Care Sector

SCOTTSDALE, Ariz., June 6, 2023 /PRNewswire/ — Amid the booming home care industry, Executive Home Care offers a compelling and rewarding franchise opportunity for entrepreneurs seeking a meaningful and profitable business venture. With a strong brand reputation, a proven business model, and comprehensive training and support, Executive Home Care stands as a leading choice for … Read more

Parkinson’s Foundation Awarded Grant from Robert W. Woodruff Foundation to Increase Access to Genetic Research in Georgia

NEW YORK and MIAMI, June 6, 2023 /PRNewswire/ — The Parkinson’s Foundation has received a grant from the Robert W. Woodruff Foundation to expand genetic testing, genetic counseling and educational research opportunities for Black and African American people with Parkinson’s disease (PD). Through PD GENEration: Mapping the Future of Parkinson’s Disease, the grant supports efforts … Read more

Life Sciences Company mend™ Receives $15 Million Series A Funding Led by S2G Ventures and Joined by a Syndicate of Leading VCs

NEW YORK, June 6, 2023 /PRNewswire/ — Mend™, a life sciences and digital health company operating at the intersection of nutrapharma, food as medicine, and behavioral health, announced today it has received a round of Series A funding. The $15M round is led by S2G Ventures, a leading multi-stage investment firm dedicated to backing innovative, … Read more

A New State-of-the-Art Facility for St. George Surgical Center

Public welcome to attend open house event   ST. GEORGE, Utah, June 6, 2023 /PRNewswire/ — St. George Surgical Center (SGSC) will host a public open house celebrating the grand opening of its new state-of-the-art surgical facility. The open house will be held Friday, June 16 from 10 a.m.–4 p.m. at 585 E. Riverside Drive St. George, … Read more

LOS NUEVOS LEXUS TX Y GX 2024

PLANO, Texas, 6 de junio de 2023 /PRNewswire-HISPANIC PR WIRE/ — Una función doble de Lexus el próximo 8 de junio a las 8:00 p. m. (hora del este). #LexusTX #LexusGX Manténgase atento para obtener más información y haga clic aquí para ver los avances anteriores de los Lexus GX y TX 2024. PRÓXIMAMENTE EL … Read more

NATURE’S BOUNTY® REDEFINES QUALITY SLEEP WITH ITS NEW TRIPLE-ACTION SLEEP3 GUMMIES

Nature’s Bounty® Sleep3 Gummies Offer a New Format of the Popular Sleep3 Tablets HOBOKEN, N.J., June 6, 2023 /PRNewswire/ — Nature’s Bounty®, a Nestlé Health Science Company and a leader in scientifically-backed vitamin and nutritional supplements, is redefining what it means to achieve quality sleep with the introduction of its new Sleep3 Gummies supplement. The new … Read more

BioLife Solutions Launches the IntelliRate™ i67C Liquid Nitrogen (LN2) Controlled-Rate Freezer

Large-Capacity Tabletop Freezer Expands Line of Controlled-Rate Freezers for Cell and Gene Therapies; Now Available for Order BOTHELL, Wash., June 6, 2023 /PRNewswire/ — BioLife Solutions, Inc. (NASDAQ: BLFS) (“BioLife” or the “Company”), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapy (CGT) and broader biopharma markets, today announced … Read more

QurAlis Receives Clinical Trial Authorisation (CTA) in European Union (EU) for QRL-201, a First-in-Class STATHMIN-2 Precision Therapy for ALS

EU CTA marks second regulatory clearance for Phase 1 ANQUR clinical trial of QRL-201 in ALS ANQUR is first-ever clinical trial to evaluate a therapy that rescues STATHMIN-2 expression in ALS patients QurAlis recently announced first patient dosed in Canada; enrollment completed in Cohort 1 portion of ANQUR CAMBRIDGE, Mass., June 6, 2023 /PRNewswire/ — … Read more

Intensity Therapeutics Reports INT230-6 Can Cause Immune Priming in Historically Quiescent Breast Cancers

INT230-6 Induced T-Cell Receptor Signaling, Macrophage Markers, and IL-18 and B-Cell Receptor Signaling Data Was Presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting on June 4, 2023 WESTPORT, Conn., June 6, 2023 /PRNewswire/ — Intensity Therapeutics, Inc. (“Intensity”), a clinical-stage biotechnology company focused on the discovery and development of proprietary, novel immune-based … Read more